Reddit: MixedAttention: Watching

The Story

News Summary

Resmed executives to attend growth conference

May 19:Resmed announces attendance at the William Blair Growth Stock Conference.

Sentiment: 50% neutral (early) → 50% neutral (late)

Impact: The narrative remained stable with no significant changes, focusing on the upcoming conference without any new developments.

Analyst ConsensusBuy (35 analysts)

Target: $281 avg

16 Buy · 14 Hold · 5 Sell

Signal

Neutral

Confidence

50%

Based on curated news sources (not retail comments)

Over the last 7 days: No significant bullish or bearish signals were identified for RMD.

SentimentNeutral

AnalysisHype

Earnings

EPS: $11.11 → $12.24 (2026 vs 2027)

▲ Expected to grow 10%

Insiders (90d)

0 buys, 4 sells

Last: SELL May 7· 33d ago

▼Net selling $2.8M

Explore

$RMD